Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1967 1
1971 2
1973 2
1975 18
1976 17
1977 25
1978 15
1979 26
1980 22
1981 20
1982 25
1983 30
1984 30
1985 65
1986 41
1987 48
1988 45
1989 54
1990 55
1991 54
1992 43
1993 36
1994 46
1995 51
1996 44
1997 46
1998 43
1999 41
2000 38
2001 35
2002 47
2003 39
2004 49
2005 49
2006 53
2007 59
2008 64
2009 68
2010 80
2011 74
2012 102
2013 103
2014 131
2015 133
2016 117
2017 104
2018 104
2019 99
2020 88
2021 59
2022 27
2023 28
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

2,466 results

Results by year

Filters applied: . Clear all
Page 1
Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy.
Zhang C, Yin K, Liu SY, Yan LX, Su J, Wu YL, Zhang XC, Zhong WZ, Yang XN. Zhang C, et al. J Immunother Cancer. 2021 Apr;9(4):e002312. doi: 10.1136/jitc-2020-002312. J Immunother Cancer. 2021. PMID: 33820821 Free PMC article.
Herein, we performed integrated multiomics analysis in one patient with early stage MPLC with remarkable tumor shrinkage in a solid nodule and no response in two subsolid nodules after treatment with three cycles of neoadjuvant pembrolizumab. Genomic heterogeneity was observed …
Herein, we performed integrated multiomics analysis in one patient with early stage MPLC with remarkable tumor shrinkage in a solid nodule a …
Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
Pritchard AL, Johansson PA, Nathan V, Howlie M, Symmons J, Palmer JM, Hayward NK. Pritchard AL, et al. PLoS One. 2018 Apr 11;13(4):e0194098. doi: 10.1371/journal.pone.0194098. eCollection 2018. PLoS One. 2018. PMID: 29641532 Free PMC article.
The identified variants were classified for pathogenicity using online databases, literature and in silico prediction tools. RESULTS: No known pathogenic autosomal dominant or previously described compound heterozygous mutations in autosomal recessive genes were observe …
The identified variants were classified for pathogenicity using online databases, literature and in silico prediction tools. RESULTS: …
Bilateral breast cancer.
Fracchia AA, Borgen PI. Fracchia AA, et al. Semin Surg Oncol. 1991 Sep-Oct;7(5):300-5. doi: 10.1002/ssu.2980070513. Semin Surg Oncol. 1991. PMID: 1775816 Review.
The risk of developing a contralateral breast cancer is influenced by the age of the patient, the presence of in situ disease, lobular histology of this new lesion, multicentricity, exposure to certain types of ionizing irradiation, and, possibly, family history of breast cancer. …
The risk of developing a contralateral breast cancer is influenced by the age of the patient, the presence of in situ disease, lobular histo …
Genetic and immune characteristics of multiple primary lung cancers and lung metastases.
Yang R, Li P, Wang D, Wang L, Yin J, Yu B, Li M, Wang S, Wang Y. Yang R, et al. Thorac Cancer. 2021 Oct;12(19):2544-2550. doi: 10.1111/1759-7714.14134. Epub 2021 Sep 12. Thorac Cancer. 2021. PMID: 34510768 Free PMC article.
At the same time, 86 differentially expressed genes (DEGs) were observed between IPM and MPLC patients with transcriptome sequencing, of which 56 DEGs were upregulated and 30 were downregulated in the IPM group compared with the MPLC group. ...
At the same time, 86 differentially expressed genes (DEGs) were observed between IPM and MPLC patients with transcriptome sequencing, …
Clinical characteristics and prognosis of patients with hypopharyngeal cancers with multiple primary cancers: A propensity score matched analysis.
Wan M, Zhao D, Liu W, Xu X, Zheng B, Xiao S, Sun Y, Wang W. Wan M, et al. Am J Otolaryngol. 2022 Mar-Apr;43(2):103297. doi: 10.1016/j.amjoto.2021.103297. Epub 2021 Dec 4. Am J Otolaryngol. 2022. PMID: 34894448
MATERIAL AND METHODS: This study included 219 patients with HPSCC treated at our center between 2008 and 2020; the clinical characteristics and prognosis of 66 patients with MPCs were analyzed. Propensity score matching (PSM) was used to balance the factors between patient …
MATERIAL AND METHODS: This study included 219 patients with HPSCC treated at our center between 2008 and 2020; the clinical characteristics …
Discrepancy Between Clinical Diagnosis and Whole-exome Sequencing-based Clonality Analysis of Synchronous Multiple Oral Cancers.
Nishii N, Hirotsu Y, Koida N, Takahashi Y, Takagawa Y, Amemiya K, Oyama T, Mochizuki H, Furusawa-Nishii E, Harada H, Omata M. Nishii N, et al. Anticancer Res. 2021 Feb;41(2):1035-1040. doi: 10.21873/anticanres.14859. Anticancer Res. 2021. PMID: 33517312
BACKGROUND/AIM: The definition of multiple oral cancers is based on the distances between the tumors. However, it is not possible to accurately predict tumor origins based only on clinical criteria. PATIENTS AND METHODS: We performed whole-exome sequencing (WES) to analyze …
BACKGROUND/AIM: The definition of multiple oral cancers is based on the distances between the tumors. However, it is not possible to accurat …
Trends in the incidence and overall survival of multiple primary cancers in Turkey.
Sert F, Caner A, Haydaroglu A. Sert F, et al. J BUON. 2020 Mar-Apr;25(2):1230-1236. J BUON. 2020. PMID: 32521930 Free article.
We aimed to present the risk of developing multiple primary cancers and to give information about the periods and prediction data regarding survival outcome for MPCs. METHODS: All patients with MPCs between 1992-2017 were included in this study. ...
We aimed to present the risk of developing multiple primary cancers and to give information about the periods and prediction data reg …
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations.
Colombino M, Paliogiannis P, Pagliarello C, Cossu A, Lissia A, Satta R, Mazzoni L, Magi S, Sini MC, Manca A, Casula M, Doneddu V, Palmieri G, Stanganelli I. Colombino M, et al. Eur J Dermatol. 2018 Apr 1;28(2):149-156. doi: 10.1684/ejd.2017.3206. Eur J Dermatol. 2018. PMID: 29180316
A significant association between BRAF mutations and Pellacani score was evident. Similarities between the index melanoma and subsequent cutaneous melanomas were observed with regards to dermoscopic features and, to a much less extent, confocal microscopy findings. …
A significant association between BRAF mutations and Pellacani score was evident. Similarities between the index melanoma and subsequ …
Primary Pseudomyogenic Hemangioendothelioma of Bone.
Inyang A, Mertens F, Puls F, Sumathi V, Inwards C, Folpe A, Lee CH, Zhang Y, Symmans P, Rubin B, Nielsen GP, Nguyen VH, Rosenberg AE. Inyang A, et al. Am J Surg Pathol. 2016 May;40(5):587-98. doi: 10.1097/PAS.0000000000000613. Am J Surg Pathol. 2016. PMID: 26872012
The advancement of predictive diagnosis and molecular mechanism in multiple primary lung cancer.
Yuan L, Liu LX, Che GW. Yuan L, et al. Chin J Cancer. 2010 May;29(5):575-8. doi: 10.5732/cjc.009.10282. Chin J Cancer. 2010. PMID: 20426912 Free article. Review.
Very often, MPLC are misdiagnosed as metastasis because of lacking efficient molecular biomarkers for prediction and diagnosis. Studies on the molecular mechanism for tumorgenesis and progression of MPLC may therefore facilitate the discovery of biomarkers for disease diag …
Very often, MPLC are misdiagnosed as metastasis because of lacking efficient molecular biomarkers for prediction and diagnosis. Studi …
2,466 results